Clinical Trial

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

Name: A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms — clinical trial record (NCT07008118)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study is being conducted to evaluate the safety and tolerability of INCA035784 in participants with myeloproliferative neoplasms.

Protocol Amendment History 1 change

notable Trial sites expanded: 23 -> 26 locations 2026-04-07

Trial Details

NCT Number	NCT07008118
Lead Sponsor	Incyte Corporation
Conditions	Myeloproliferative Neoplasms
Enrollment	120 participants
Start Date	2025-10-01
Primary Completion	2028-03-14 (estimated)
Study Completion	2029-12-14 (estimated)
Updated on ClinicalTrials.gov	2026-08-06